✦ LIBER ✦

Non-smoking and concurrent immunosuppressive use are predictors of response to infliximab in patients with Crohn’s disease

✍ Scribed by M.A Parsi; S Richardson; J.P Achkar; J Katz; D Seidner; J.F.G Orozco; B Lashner; A Brzezinski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discussion on predictors of response to

✍ Daan Hommes 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Does smoking decrease the response to in

✍ Mansour A. Parsi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

Oral ulcerations are associated with the

✍ A. R. Sánchez; R. S. Rogers III; P. J. Sheridan 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

Factors associated with the loss of resp

✍ Koji Sono; Akihiro Yamada; Yasushi Yoshimatsu; Nobuo Takada; Yasuo Suzuki 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 578 KB

Smoking and immunomodulators do not infl

✍ David S. Fefferman; Parag J. Lodhavia; Mazen Alsahli; Kenneth R. Falchuk; Mark A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

565 Novel Infliximab (IFX) and Antibody-

✍ Brian G. Feagan; Sharat Singh; Steven Lockton; Scott Hauenstein; Linda Ohrmund; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 101 KB